Site name unknown, Mannheim 68135

Phase	Trial	Trial Status [desc]	Site Status	Drug	NCT#
3	Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (Resistant at 400 mg Imatinib)	Terminated	Not yet activated	Sunitinib or Imatinib	NCT00372567
2	A Study of R1507 in Patients With Recurrent or Refractory Sarcoma	Does not allow GIST	Closed	R1507	NCT00642941
3	Efficacy and Safety of AMN107 Compared With Current Treatment Options in Patients With GIST Who Have Failed Both Imatinib and Sunitinib (ENEST)	Completed	Closed	Nilotinib	NCT00471328
2	Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate	Completed	Closed	Imatinib + RAD001	NCT00510354
2	Treatment of Patients With RAD001 Who Have Progressive Sarcoma	Completed	Closed	Everolimus	NCT00767819